A retrospective cohort study on the impact of gonadotropin dose on embryo quality and pregnancy outcome: identification of optimal dose range - Report - MDSpire

A retrospective cohort study on the impact of gonadotropin dose on embryo quality and pregnancy outcome: identification of optimal dose range

  • By

  • Run Zhao

  • Linlin Che

  • Xiao Li

  • Xiaofang Li

  • Qianyan Song

  • June 30, 2026

  • 0 min

Share

Clinical Report: Evaluating the Influence of Gonadotropin Dosage on Embryo Quality

Overview

This study analyzes the impact of gonadotropin dosage on embryo quality and pregnancy outcomes in IVF patients.

Background

Infertility affects approximately 18% of couples in China, making assisted reproductive technology (ART) crucial for many. Controlled ovarian stimulation (COS) using gonadotropins is a key component of ART, influencing the success rates of in vitro fertilization (IVF). Understanding the optimal gonadotropin dosage is essential for improving embryo quality and pregnancy outcomes.

Data Highlights

Gn Dose GroupExcellent Embryos RateClinical Pregnancy RateLive Birth RateAbortion Rate
Group 1 (≤1,550 IU)HigherHigherHigherLower
Group 2 (1,550 IU < Gn ≤2,194 IU)ModerateModerateModerateModerate
Group 3 (2,194 IU < Gn ≤2,700 IU)LowerLowerLowerHigher
Group 4 (>2,700 IU)LowestLowestLowestHighest

Key Findings

  • Group 1 had significantly higher rates of excellent embryos compared to groups 2, 3, and 4.
  • Clinical pregnancy and live birth rates were significantly higher in group 1.
  • Abortion rates were significantly lower in group 1 compared to other groups.
  • Blastocyst formation rates were higher in groups 1 and 2 than in groups 3 and 4.
  • Total gonadotropin dosage was identified as an independent risk factor for positive HCG rates, abortion, and live birth.
  • Increases in gonadotropin dosage above certain thresholds resulted in decreased rates of blastocyst formation and live births.

Clinical Implications

Monitoring gonadotropin dosage may help mitigate risks associated with both low and high gonadotropin levels.

Conclusion

The study highlights the significant influence of gonadotropin dosage on embryo quality and pregnancy outcomes.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- LH supplementation in ovarian stimulation: propensity score and generalized estimating equations analysis over 2000 embryos
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Effectiveness of Gonadotropin Treatment for Stimulating Spermatogenesis and Restoring Fertility in Men with Abnormal Gonadotropin Levels
  3. Frontiers in Endocrinology, 2026 -- Non-linear saturation threshold of gonadotropin dose on cumulative live birth rates in advanced-age women with polycystic ovary syndrome: a retrospective cohort study
  4. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline
  5. ESHRE, 2025 -- ESHRE update on ovarian stimulation for IVF/ICSI
  6. Frontiers in Endocrinology — Analysis of factors that increase serum progesterone levels on the day of hCG administration in gonadotropin-releasing hormone antagonist cycles
  7. ESHRE Guidelines
  8. ASRM Guidelines
  9. https://www.eshre.eu/-/media/sitecore-files/Guidelines/COS/2025/2025_Annex-6_Summary-of-findings-tables_.pdf
  10. Frontiers | Luteinizing hormone activity in ovarian stimulation: comparative efficacy and safety of gonadotropins versus recombinant follicle-stimulating hormone—a systematic review and meta-analysis
  11. Frontiers | LH supplementation in ovarian stimulation: propensity score and generalized estimating equations analysis over 2000 embryos

Original Source(s)

Related Content